CVRdatabase
Menu

XGX Pharma ApS

Private limited companyCVR 32289290København KActive

XGX Pharma ApS is a private limited company, based in København K, active in wholesale of pharmaceutical goods and nursing supplies, founded in 2009. Net profit rose 261% from 2024 to 2025, ending at DKK 16.1m. Profit has grown three years in a row. Equity grew to DKK 30.8m in 2025.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 32.3m+101.7% vs. 2024
Net profitDKK 16.1m+260.9% vs. 2024
EquityDKK 30.8m+64.5% vs. 2024
Employees5latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit rose 102% (2024 → 2025), to DKK 32.3m.
  • Net profit rose 261% (2024 → 2025), to DKK 16.1m.
  • Equity rose 65% (2024 → 2025), to DKK 30.8m.

Management and owners, last 24 months

  • New in management: Per Anders Larnholt (chair of the board, 21/07/2025) and Johan Frödin (board member, 21/07/2025).
  • Stepped down: Jens-Nikolaj Schøier (board member, 21/07/2025), Lars Karlsmose (board member, 21/07/2025) and Mohammad Sohail Asghar (chair of the board, 21/07/2025).
  • New owners registered: Unimedic Pharma AB (21/07/2025).
  • No longer registered as owner: Msa ApS (21/07/2025), JCNS Holding ApS (21/07/2025) and Schøier Holding ApS (21/07/2025).

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 5mDKK 0DKK 5mDKK 10mDKK 15mDKK 20mDKK 25mDKK 30m202020212022202320242025
EquityNet profit
Financial figures for XGX Pharma ApS
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit15,22614,5152,9188,10116,03432,338+101.7%
Operating profit (EBIT)10,8669,073−2,2901,4766,53721,199+224.3%
Profit before tax8,2048,932−2,6816245,67320,509+261.5%
Net profit6,0047,249−1,8434614,45316,074+260.9%
Total assets24,93821,25727,64029,60139,00655,115+41.3%
Equity12,92013,16913,79914,26018,71330,787+64.5%
Liabilities10,5735,58012,17113,50917,24120,311+17.8%
Average number of employees234540−100%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 5mDKK 10mDKK 15mDKK 20mDKK 25mDKK 30m202020212022202320242025
Gross profitMedian, the industry (232 companies)

Annual reports

6 financial years
Annual reports for XGX Pharma ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202526/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202428/03/2025The companyPDFXBRL
202301/01/2023 – 31/12/202317/06/2024The companyPDFXBRL
202201/01/2022 – 31/12/202226/06/2023The companyPDFXBRL
202101/01/2021 – 31/12/202121/06/2022The companyPDFXBRL
202001/01/2020 – 31/12/202031/03/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
012345609/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

232 companies in the database

Comparison with the other companies in wholesale of pharmaceutical goods and nursing supplies based on the latest financial year.

Gross profitDKK 32.3mNo. 73 of 232
Better than 69% of the companies in the industry
EquityDKK 30.8mNo. 78 of 232
Better than 67% of the companies in the industry
Number of employees5No. 217 of 232
Better than 6% of the companies in the industry

Industry median: gross profit DKK 11.2m, net profit DKK 1.8m, equity DKK 9.6m, 9 employees.

DKK 100kDKK 1.4mDKK 19.1mDKK 263.2mDKK 1.5bnHere
Distribution of gross profit for 225 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 804of 69,742
Better than 99%
No. 4,387of 69,964
Better than 94%
Same industry and fewer than 20 employees150 companies in the comparison
No. 13of 150
Better than 92%
No. 22of 150
Better than 86%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 2,204of 24,791
Better than 91%
No. 3,323of 24,909
Better than 87%
All companies of type ApS66,508 companies in the comparison
No. 1,305of 66,379
Better than 98%
No. 3,105of 66,505
Better than 95%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Wholesale of pharmaceutical goods and nursing supplies
Gross profit
  1. XGX Pharma ApSDKK 32.3m
  2. Ambu A/SDKK 3.6bn
  3. Stada Nordic ApSDKK 687m
Net profit
  1. XGX Pharma ApSDKK 16.1m
  2. Ambu A/SDKK 609m
  3. Stada Nordic ApSDKK 54.6m
Equity
  1. XGX Pharma ApSDKK 30.8m
  2. Ambu A/SDKK 6bn
  3. Stada Nordic ApSDKK 346.3m
Employees
  1. XGX Pharma ApS5
  2. Ambu A/S619
  3. Stada Nordic ApS51

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Unimedic Pharma AB100%
XGX Pharma ApS
Subsidiaries and ownership shares

Subsidiaries are shown only if they are in the database.

Management

3 active registrations

Executive management

Executive management at XGX Pharma ApS
NameRoleAppointed
Jens-Nikolaj SchøierCEO01/12/2017

Board of directors

Board of directors at XGX Pharma ApS
NameRoleAppointed
Per Anders LarnholtChair of the board21/07/2025
Johan FrödinBoard member21/07/2025
Auditor
KPMG P/S
Founders
Msa ApS
Former management (7)
Former management at XGX Pharma ApS
NameRoleAppointedResigned
Mohammad Sohail AsgharDirector14/07/200901/12/2017
Mohammad Sohail AsgharBoard member01/11/201809/05/2022
Per LudvigsenChair of the board01/11/201827/01/2020
Jens-Nikolaj SchøierBoard member01/11/201821/07/2025
Lars KarlsmoseBoard member22/11/201921/07/2025
Rolf EckersbergChair of the board27/01/202010/05/2022
Mohammad Sohail AsgharChair of the board10/05/202221/07/2025

Signing rule: Selskabet tegnes af direktøren i forening med ét bestyrelsesmedlem

Address and production units

2 active production units

Frederiksgade 11
1265 København K

København Municipality · Postcode 1265

Other companies at the address (1)

Production units
Production unitAddressEmployeesP number
Vital Pharma Nordic ApSTuborgvej 5, 2900 Hellerup41016394617
XGX Pharma ApSFrederiksgade 11, st. th, 1265 København K–1027204852

Purpose

Selskabets formål er at drive virksomhed med fremstilling, markedsføring og distribution af medicinske produkter samt at udøve enhver aktivitet, der efter ledelsens skøn er forbundet hermed.

The purpose is quoted from the register in Danish.

Changes year by year

56 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
202510 changesmanagement 5 · ownership 4 · accounts 1
  • Johan Frödin appointed board member
  • Per Anders Larnholt appointed chair of the board
  • Mohammad Sohail Asghar stepped down as chair of the board
  • Lars Karlsmose stepped down as board member
  • Jens-Nikolaj Schøier stepped down as board member
  • Unimedic Pharma AB registered as owner (100%)
  • Schøier Holding ApS is no longer registered as owner
  • MSA ApS is no longer registered as owner
  • JCNS Holding ApS is no longer registered as owner
  • Annual report for 2024 published
20248 changesname 1 · accounts 1 · ownership 6
  • Name changed from VITAL PHARMA NORDIC ApS to XGX Pharma ApS
  • Annual report for 2023 published
  • Schøier Holding ApS registered as owner (33.33%)
  • MSA ApS registered as owner (33.33%)
  • JCNS Holding ApS registered as owner (20%)
  • Schøier Holding ApS is no longer registered as owner
  • MSA ApS is no longer registered as owner
  • JCNS Holding ApS is no longer registered as owner
20231 changeaccounts 1
  • Annual report for 2022 published
20227 changescapital 1 · accounts 1 · management 3 · ownership 2
  • Share capital changed from 132,979 DKK to 400,000 DKK
  • Annual report for 2021 published
  • Mohammad Sohail Asghar appointed chair of the board
  • Rolf Eckersberg stepped down as chair of the board
  • E CONSULT ApS is no longer registered as owner
  • Mohammad Sohail Asghar stepped down as board member
  • E CONSULT ApS registered as owner (5%)
20212 changesaddress 1 · accounts 1
  • Moved to Frederiksgade 11, st. th, 1265 København K
  • Annual report for 2020 published
20202 changesmanagement 2
  • Rolf Eckersberg appointed chair of the board
  • Per Ludvigsen stepped down as chair of the board
20197 changescapital 1 · management 1 · ownership 5
  • Share capital changed from 125,000 DKK to 132,979 DKK
  • Lars Karlsmose appointed board member
  • Schøier Holding ApS registered as owner (33.33%)
  • MSA ApS registered as owner (33.33%)
  • JCNS Holding ApS registered as owner (10%)
  • Schøier Holding ApS is no longer registered as owner
  • MSA ApS is no longer registered as owner
20183 changesmanagement 3
  • Jens-Nikolaj Schøier appointed board member
  • Per Ludvigsen appointed chair of the board
  • Mohammad Sohail Asghar appointed board member
20176 changesownership 4 · management 2
  • Schøier Holding ApS registered as owner (50%)
  • Jens-Nikolaj Schøier is no longer registered as owner
  • Jens-Nikolaj Schøier appointed ceo
  • Mohammad Sohail Asghar stepped down as director
  • Jens-Nikolaj Schøier registered as owner (50%)
  • Chrisyda Management Ltd. is no longer registered as owner
20162 changesownership 2
  • MSA ApS registered as owner (50%)
  • Chrisyda Management Ltd. registered as owner (50%)
20151 changeaddress 1
  • Moved to Tuborgvej 5, 2900 Hellerup
20131 changeaddress 1
  • Moved to Automatikvej 1, 3, 2860 Søborg
20111 changeaddress 1
  • Moved to Bistrup Hegnsvej 1B, 3460 Birkerød
20101 changeaddress 1
  • Moved to Rolighedsvej 10, 3. tv, 1958 Frederiksberg C
20093 changesname 1 · founded 1 · management 1
  • Name changed from VITAL PHARMA NORDIC HOLDING ApS to VITAL PHARMA NORDIC ApS
  • Registered as VITAL PHARMA NORDIC HOLDING ApS
  • Mohammad Sohail Asghar appointed director

Related companies

Same industry in København

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction